Dr. Christopher Birigwa is a research fellow in the Department of Gastrointestinal Surgery at Renmin Hospital of Wuhan University, Wuhan, China. He is currently doing his MD in gastrointestinal oncology at Wuhan University under Professor Jianfei Luo's supervision. His research focuses on non‑invasive biomarkers for colorectal cancer, liquid biopsy, and the integration of epigenetic and metabolic markers for early cancer detection. He has experience in molecular biology techniques, including real‑time PCR, ELISA, and DNA methylation analysis. His work aims to develop affordable, scalable diagnostic tools for low‑resource settings.
Dr. Christopher Birigwa is a research fellow in the Department of Gastrointestinal Surgery at Renmin Hospital of Wuhan University, Wuhan, China. He is currently doing his MD in gastrointestinal oncology at Wuhan University under Professor Jianfei Luo's supervision. His research focuses on non‑invasive biomarkers for colorectal cancer, liquid biopsy, and the integration of epigenetic and metabolic markers for early cancer detection. He has experience in molecular biology techniques, including real‑time PCR, ELISA, and DNA methylation analysis. His work aims to develop affordable, scalable diagnostic tools for low‑resource settings.